hSTM-418

N/A

Report date: 2022/04/20 10:24:33

Base Information

Drug NamehSTM-418

Drug Alias NamehSTM-418

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionAnti-PD-1

TargetsProgrammed cell death protein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSTCube Inc

China Registration ClassN/A

Active CompaniesSTCube Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A